EUVIMEDEUVIMED entdecken
Crossref

Increased Na V 1.2 expression and its interaction with CaM contribute to the hyperexcitability induced by prolonged inhibition of CaMKII

Hongyue Liang iD, Ling Qin, Rui Feng, Jaehoon Shim iD, Xuan Huang, Xiaoxue Xu, Dongyi Zhao, Zhiyi Yu iD, Tomasz Boczek, Meixuan Li, Yu Tong, Junwei Huang und 11 weitere

Epilepsia · 2025

DOI: 10.1111/epi.18377 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Epilepsia, 2025. Verfasst von Hongyue Liang und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacology, School of Pharmacy, China Medical University, Shenyang, China. Hauptthemen laut MEDLINE: Calcium-Calmodulin-Dependent Protein Kinase Type 2, NAV1.2 Voltage-Gated Sodium Channel, Calmodulin. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: Shenyang Young and Middle-aged Science and Technology Innovation Talent Support Program, Natural Science Foundation of Liaoning Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Dysfunction of calcium/calmodulin (CaM)–dependent kinase II (CaMKII) has been involved in hyperexcitability‐related disorders including epilepsy. However, the relationship between CaMKII and neuronal excitability remains unclear.

Methods

Neuronal excitability was detected in vivo and in vitro by electroencephalography (EEG), patch clamp and multi‐electrode array (MEA), respectively. Next, we assessed the currents of voltage‐gated sodium channels (VGSCs) by patch clamp, and mRNA and protein expressions of VGSCs were determined by real‐time quantitative reverse transcription‐polymerase chain reaction (qRT‐PCR) and western blot, respectively. Meanwhile, the association between the nuclear receptor subfamily 4 group A member 2 ( NR4A2 ) and promoters of Scn2a , was determined by chromatin immunoprecipitation (ChIP)‐qPCR. In addition, we utilized co‐immunoprecipitation (Co‐IP), immunofluorescence labeling, and pull‐down to determine the interaction between VGSCs and CaM.

Results

Prolonged CaMKII inhibition by KN93, an inhibitor of CaMKII, for 24 h and CaMKII knockdown induced more seizure‐like events in Wistar rats, TRM rats and C57BL/6 mice, and led to hyperexcitability in primary hippocampal neurons and human induced‐pluripotent stem cell (hiPSC)–derived cortical neurons. In addition, prolonged CaMKII inhibition resulted in elevated persistent sodium current (I NaP )/transient sodium current (I NaT ) and increased mRNA and protein expressions of Na V 1.2. Meanwhile, prolonged CaMKII inhibition by KN93 decreased NR4A2 expression and contributed to a transcriptional repression role of NR4A2 in Scn2a regulation, leading to increased Na V 1.2 expression. Moreover, an increased interaction between Na V 1.2 and CaM was attributable to enhanced binding of CaM to the isoleucine‐glutamine (IQ) domain at the C‐terminus of the Na V 1.2 channel, which may also lead to the potentiation in I NaP /I NaT and channel activity. Furthermore, a peptide that antagonized CaM binding to Na V 1.2 IQ domain (ACNp) rescued hyperexcitability following prolonged CaMKII inhibition. Significance We unveiled that prolonged CaMKII inhibition induced hyperexcitability through increasing the expression of Na V 1.2 and its association with CaM. Thus, our study uncovers a novel signaling mechanism by which CaMKII maintains appropriate neuronal excitability.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Calcium-Calmodulin-Dependent Protein Kinase Type 2NAV1.2 Voltage-Gated Sodium ChannelCalmodulinAnimalsRatsMiceMice, Inbred C57BLMaleRats, WistarNeuronsBenzylaminesHippocampusHumansSulfonamidesElectroencephalographyBenzenesulfonamides

Stichwörter der Autor:innen

NaV1.2 channelcalcium/calmodulin dependent kinase IIcalmodulinepilepsyhyperexcitability

Substanzen

Calcium-Calmodulin-Dependent Protein Kinase Type 2NAV1.2 Voltage-Gated Sodium ChannelCalmodulinBenzylaminesKN 93SulfonamidesBenzenesulfonamides

Autor:innen und Institutionen

  • Department of Clinical Pharmacology, School of Pharmacy, China Medical University, Shenyang, China.
  • Department of Physiology, China Medical University, Shenyang, China.
  • Department of Pharmaceutical Toxicology, School of Pharmacy, China Medical University, Shenyang, China.
  • Department of Neurobiology, Boston Children's Hospital, Boston, Massachusetts, USA.
  • Department of Neurology, The First Hospital of China Medical University, Shenyang, China.
  • Division of Medicinal Chemistry, School of Pharmaceutical Sciences, Shandong University, Jinan, Shandong, China.

ORCID-Profile: Hongyue Liang, Jaehoon Shim, Zhiyi Yu, Feng Guo

Förderung

  • Shenyang Young and Middle-aged Science and Technology Innovation Talent Support Program
  • Natural Science Foundation of Liaoning Province
  • National Natural Science Foundation of China

Zitieren

APA

Liang, H., Qin, L., Feng, R., Shim, J., Huang, X., Xu, X., Zhao, D., Yu, Z., Boczek, T., Li, M., Tong, Y., Huang, J., Gao, Q., Wang, L., Cao, X., Liu, D., Du, K., Xu, J., Zhao, Y., …, & Guo, F. (2025). Increased Na V 1.2 expression and its interaction with CaM contribute to the hyperexcitability induced by prolonged inhibition of CaMKII. Epilepsia. https://doi.org/10.1111/epi.18377

Vancouver

Liang H, Qin L, Feng R, Shim J, Huang X, Xu X, et al. Increased Na V 1.2 expression and its interaction with CaM contribute to the hyperexcitability induced by prolonged inhibition of CaMKII. Epilepsia. 2025. doi:10.1111/epi.18377

BibTeX
@article{Liang2025,
  author = {Liang, Hongyue and Qin, Ling and Feng, Rui and Shim, Jaehoon and Huang, Xuan and Xu, Xiaoxue and Zhao, Dongyi and Yu, Zhiyi and Boczek, Tomasz and Li, Meixuan and Tong, Yu and Huang, Junwei and Gao, Qinghua and Wang, Li and Cao, Xinyu and Liu, Dongxin and Du, Ke and Xu, Jianjun and Zhao, Yue and Wang, Wuyang and Seehus, Corey Ray and Zhao, Weidong and Guo, Feng},
  title = {Increased Na V 1.2 expression and its interaction with CaM contribute to the hyperexcitability induced by prolonged inhibition of CaMKII},
  journal = {Epilepsia},
  year = {2025},
  doi = {10.1111/epi.18377}
}
Kostenlos starten →